top of page
Create Your First Project
Start adding your projects to your portfolio. Click on "Manage Projects" to get started
AI-designed, bespoke mRNA therapy reduces melanoma recurrence, metastasis, and death - BioXconomy
Date
September 7, 2026
Link
Merck and Moderna’s Phase III clinical trial demonstrates the effectiveness of bespoke mRNA therapy, hinting at potential treatments for other cancers.
bottom of page